0001209191-19-058217.txt : 20191126
0001209191-19-058217.hdr.sgml : 20191126
20191126200100
ACCESSION NUMBER: 0001209191-19-058217
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191122
FILED AS OF DATE: 20191126
DATE AS OF CHANGE: 20191126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Howton David T
CENTRAL INDEX KEY: 0001529297
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 191252771
MAIL ADDRESS:
STREET 1: VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-274-4000
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-11-22
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001529297
Howton David T
215 FIRST STREET, SUITE 415
CAMBRIDGE
MA
02142
0
1
0
0
EVP, General Counsel
Common Stock
2019-11-22
4
M
0
5685
13.71
A
24388
D
Common Stock
2019-11-22
4
M
0
4025
13.71
A
28413
D
Common Stock
2019-11-22
4
M
0
8580
13.90
A
36993
D
Common Stock
2019-11-22
4
S
0
18290
105.00
D
18703
D
Common Stock
2019-11-22
4
S
0
3753
105.00
D
14950
D
Common Stock
2019-11-22
4
S
0
2957
105.00
D
11993
D
Common Stock
2019-11-22
4
M
0
2440
13.71
A
14433
D
Common Stock
2019-11-22
4
M
0
52
13.71
A
14485
D
Common Stock
2019-11-22
4
M
0
5590
13.90
A
20075
D
Common Stock
2019-11-22
4
M
0
7900
23.85
A
27975
D
Common Stock
2019-11-22
4
F
0
2804
107.02
D
25171
D
Stock option (right to buy)
13.71
2019-11-22
4
M
0
5685
0.00
D
2017-02-28
2026-02-28
Common Stock
5685
1280
D
Stock option (right to buy)
13.71
2019-11-22
4
M
0
4025
0.00
D
2016-09-19
2026-02-28
Common Stock
4025
1858
D
Stock option (right to buy)
13.90
2019-11-22
4
M
0
8580
0.00
D
2016-02-27
2025-02-27
Common Stock
8580
18579
D
Stock option (right to buy)
13.71
2019-11-22
4
M
0
2440
0.00
D
2017-02-28
2026-02-28
Common Stock
2440
2470
D
Stock option (right to buy)
13.71
2019-11-22
4
M
0
52
0.00
D
2016-09-19
2026-02-28
Common Stock
52
18
D
Stock option (right to buy)
13.90
2019-11-22
4
M
0
5590
0.00
D
2016-02-27
2025-02-27
Common Stock
5590
0
D
Stock option (right to buy)
23.85
2019-11-22
4
M
0
7900
0.00
D
2013-11-05
2022-11-05
Common Stock
7900
5118
D
This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.
Represents shares of Common Stock owned by the reporting person that were delivered to the Company to pay the aggregate exercise price with respect to the option exercises reported in rows 4-7 in Table II of this Form 4 filing.
/s/ David Tyronne Howton
2019-11-26